|
|
|
| |
|
|
| |
The latest neurology news from News Medical |
|
|
|
 | | |
 Advancing Neuroscience with High-Content Imaging
Human‑relevant 3D brain models are advancing neuroscience by enabling more accurate neurotoxicity and functional studies. If you're looking to enhance these emerging approaches, Yokogawa’s high‑content imaging platforms deliver the sensitivity and scalability needed to support cutting‑edge neurobiology and bMPS research.
| |
|
|
| | | | |  A perspective in The Journal of Clinical Investigation argues that environmental exposures may interact with the gut microbiome and intestinal barrier to trigger biological processes linked to Parkinson’s disease. The authors propose that cumulative environmental stressors can erode host resilience, promoting α-synuclein pathology, immune activation, and neurodegeneration. | | | | |  Researchers used single-nucleus RNA sequencing and chromatin accessibility profiling to map human hippocampal neurogenesis across adulthood, aging, and Alzheimer’s disease. They found that chromatin accessibility changes, more than gene expression alone, distinguish healthy aging, preclinical pathology, Alzheimer’s disease, and cognitive resilience in SuperAgers. | | | | |  This review examines how nature exposure impacts brain function, stress reduction, and emotional well-being, highlighting gaps and future research directions. | | | | |  Researchers developed and validated ElasticNet machine learning models that predict 12-month MMSE and BADL outcomes in Alzheimer’s disease and mild cognitive impairment using routinely collected clinical data. The cognitive model demonstrated external validation in ADNI, showing that individualized progression forecasting is feasible without biomarkers or neuroimaging. | | | | |  Research shows food cues activate brain reward signals, leading to eating without hunger, shedding light on obesity and appetite regulation mechanisms. | | | | |  For people with chronic migraine, taking glucagon-like peptide-1 receptor agonists, or GLP-1 drugs, for other conditions such as diabetes and weight loss, was associated with fewer emergency department visits and hospitalizations overall, and with less need for medications used to stop and prevent migraine attacks, according to a preliminary study released March 1, 2026, that will be presented at the American Academy of Neurology's 78th Annual... | | | | | __639087238110623648_multisizecolor_150_custom.jpg) A team of Korean researchers has, for the first time in the world, developed a technology capable of enabling early diagnosis of major neurological disorders, including epilepsy, Parkinson's disease, and schizophrenia, using only a small amount of saliva. | |
|
|
|  | | | How would you rate today's newsletter?
| |
|
|
| | | |
 |
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now. |
| |
|
|
|
|
|
|
|
